HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $64,000 | -37.3% | 11,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -14.3% | 11,200 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $119,000 | -60.3% | 11,100 | -42.5% | 0.00% | -66.7% |
| Q2 2021 | $300,000 | -11.5% | 19,300 | -7.7% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | -42.3% | 20,900 | -24.8% | 0.00% | -50.0% |
| Q4 2020 | $588,000 | +11.4% | 27,800 | -21.9% | 0.01% | 0.0% |
| Q3 2020 | $528,000 | +76.6% | 35,600 | +75.4% | 0.01% | +50.0% |
| Q2 2020 | $299,000 | -66.1% | 20,300 | -43.8% | 0.00% | -60.0% |
| Q1 2019 | $882,000 | -3.7% | 36,100 | +2.3% | 0.01% | -16.7% |
| Q4 2018 | $916,000 | -47.2% | 35,300 | -35.6% | 0.01% | -40.0% |
| Q3 2018 | $1,734,000 | +191.9% | 54,800 | +258.2% | 0.02% | +185.7% |
| Q2 2018 | $594,000 | -25.0% | 15,300 | -46.7% | 0.01% | -30.0% |
| Q1 2018 | $792,000 | +67.1% | 28,700 | +9.5% | 0.01% | +66.7% |
| Q4 2017 | $474,000 | +3.3% | 26,200 | -14.4% | 0.01% | 0.0% |
| Q1 2017 | $459,000 | – | 30,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 37,999 | $706,000 | 24.13% |
| TANG CAPITAL MANAGEMENT LLC | 5,744,096 | $106,783,000 | 14.43% |
| BRIDGER MANAGEMENT, LLC | 2,846,555 | $52,917,000 | 4.15% |
| First Light Asset Management, LLC | 1,098,723 | $20,425,000 | 2.84% |
| Broadfin Capital, LLC | 657,998 | $12,232,000 | 2.66% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,606,942 | $29,873,000 | 1.75% |
| EMORY UNIVERSITY | 129,020 | $2,398,000 | 1.69% |
| Mesirow Financial Investment Management, Inc. | 24,112 | $430,000 | 1.57% |
| Congress Park Capital LLC | 109,665 | $1,945,000 | 1.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 830,821 | $15,445,000 | 1.52% |